Antibody Immunity Shapes Flu Strain Dominance, Study Finds

⁣ Updated ⁢June 05, 2025
⁣

Individual variations in antibody immunity are⁤ a key factor in ⁤determining ‍which influenza (flu) strains become dominant within a population, according to a new study published⁤ in eLife. The research highlights the importance of personalized immune ⁤responses in shaping flu evolution and vaccine effectiveness.

The study, led ⁤by Caroline Kikawa⁣ at the University‍ of Washington and Fred Hutch Cancer ⁣Center, used a high-throughput ‍sequencing-based assay to ⁢measure antibody immunity against‍ circulating H3N2 flu ⁣strains in both children and adults. ⁢This⁣ method allowed researchers to analyze a large number of samples and gain a‍ detailed understanding of population-level immunity to the flu.

Flu viruses⁢ constantly mutate to evade antibodies generated by the ⁢immune system, requiring regular ⁢updates⁣ to ⁣vaccines. The human immune response is influenced by prior infections and vaccinations, leading to meaningful variation in immunity ⁤across individuals. ⁤The ‍research⁤ team developed a neutralization assay to assess ‍how well individual serum samples block infection by different flu viruses.

The team analyzed 150 serum samples collected in the U.S. in 2023, measuring⁣ neutralization ⁢titers ⁣against 78 flu ⁣variants. The results revealed⁢ wide variation⁤ in neutralization responses, with some children showing strong immunity⁢ to nearly all tested strains, while others⁢ had weaker responses. Adults generally showed more consistent immunity but still displayed individual variation. The highest rates of neutralization were observed in a subset of children,‍ suggesting that neutralizing antibody responses are⁢ strongest to strains ⁣encountered early in life.

Researchers⁤ compared neutralization‍ titers with the growth rates of each viral strain during the 2023 flu season. They found that ⁢strains that spread most successfully were those that escaped neutralization in a larger fraction of the sera.Andrea⁤ Loes, Staff Scientist at Fred Hutch cancer Center, said that individual-level immune variation, ⁢not just average immunity, is a key ‍factor in determining which flu⁢ strains ‍are most successful.

“Our findings show that individual-level immune variation, not just average immunity across the population, is a key factor in determining which ⁣flu strains‍ are most successful,” said Loes.

The study’s findings suggest that large-scale sequencing-based neutralization assays can definitely help inform our⁢ understanding of flu virus evolution. The authors noted that the samples were collected from a limited set⁢ of locations and age groups, which ⁣may not fully reflect global patterns⁢ of immunity. Most child samples ⁤came from a hospital in Seattle,⁣ while adult ⁣samples were drawn from vaccinated cohorts in Philadelphia and Australia.

What’s next

Jesse Bloom, Professor at Fred Hutch⁣ Cancer Center, said the study provides ⁣a framework for understanding how⁣ diverse immune histories can affect viral evolution.Bloom ‍added that these methods could complement existing surveillance⁤ systems and support vaccine composition decisions by providing more ⁢detailed insights into population immunity, perhaps ⁣improving⁢ future flu vaccines and public health⁢ strategies for influenza prevention.